LVM Capital Management Ltd. MI lowered its position in CVS Health Corp (NYSE:CVS) by 96.0% during the 4th quarter, HoldingsChannel reports. The fund owned 4,510 shares of the pharmacy operator’s stock after selling 106,924 shares during the period. LVM Capital Management Ltd. MI’s holdings in CVS Health were worth $327,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. Pathstone Family Office LLC boosted its holdings in CVS Health by 341.0% in the second quarter. Pathstone Family Office LLC now owns 1,270 shares of the pharmacy operator’s stock worth $2,353,000 after acquiring an additional 982 shares in the last quarter. Wealthcare Advisory Partners LLC boosted its holdings in CVS Health by 330.3% in the third quarter. Wealthcare Advisory Partners LLC now owns 1,291 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 991 shares in the last quarter. Fieldpoint Private Securities LLC boosted its holdings in CVS Health by 333.3% in the second quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,000 shares in the last quarter. Arcadia Investment Management Corp MI boosted its holdings in CVS Health by 119.6% in the third quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock worth $108,000 after acquiring an additional 726 shares in the last quarter. Finally, MPS Loria Financial Planners LLC bought a new position in CVS Health in the second quarter worth approximately $119,000. Institutional investors and hedge funds own 80.81% of the company’s stock.
A number of research analysts have recently weighed in on CVS shares. Robert W. Baird restated a “hold” rating and issued a $77.00 target price on shares of CVS Health in a report on Friday, October 27th. Needham & Company LLC upgraded CVS Health from a “hold” rating to a “buy” rating and raised their target price for the company from $69.02 to $79.00 in a report on Friday, November 10th. Deutsche Bank restated a “hold” rating on shares of CVS Health in a report on Tuesday, December 5th. Mizuho set a $90.00 target price on CVS Health and gave the company a “buy” rating in a report on Tuesday, October 24th. Finally, Raymond James Financial restated a “buy” rating on shares of CVS Health in a report on Monday, December 4th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company. CVS Health currently has a consensus rating of “Buy” and a consensus price target of $87.82.
Shares of CVS Health Corp (NYSE:CVS) opened at $71.90 on Friday. The company has a market capitalization of $72,944.85, a price-to-earnings ratio of 12.15, a P/E/G ratio of 1.22 and a beta of 0.93. CVS Health Corp has a fifty-two week low of $66.45 and a fifty-two week high of $84.00. The company has a current ratio of 1.02, a quick ratio of 0.52 and a debt-to-equity ratio of 0.59.
CVS Health (NYSE:CVS) last issued its quarterly earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 EPS for the quarter, topping the Zacks’ consensus estimate of $1.88 by $0.04. The business had revenue of $48.39 billion for the quarter, compared to analyst estimates of $47.54 billion. CVS Health had a return on equity of 17.21% and a net margin of 3.58%. CVS Health’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same period last year, the company posted $1.71 earnings per share. analysts anticipate that CVS Health Corp will post 6.38 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Friday, February 2nd. Investors of record on Wednesday, January 24th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, January 23rd. This represents a $2.00 dividend on an annualized basis and a yield of 2.78%. CVS Health’s dividend payout ratio (DPR) is currently 30.91%.
COPYRIGHT VIOLATION WARNING: “LVM Capital Management Ltd. MI Sells 106,924 Shares of CVS Health Corp (CVS)” was first reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this piece can be read at https://www.chaffeybreeze.com/2018/02/18/lvm-capital-management-ltd-mi-sells-106924-shares-of-cvs-health-corp-cvs.html.
About CVS Health
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.